"March 11, 2014 - The U.S. Food and Drug Administration allowed marketing of the first device as a preventative treatment for migraine headaches. This is also the first transcutaneous electrical nerve stimulation (TENS) device specifically "...
- Patient Information:
Details with Side Effects
DOSAGE AND ADMINISTRATION
Procedure: For the best results, dosage should start at the first sign of an attack. Adults: Take 2 tablets at the start of attack; 1 additional tablet every 1/2 hour, if needed for full relief (maximum 6 tablets per attack, 10 per week).
Maximum Adult Dosage: Total dose for any one attack should not exceed 6 tablets. Total weekly dosage should not exceed 10 tablets. Ergotamine tartrate and caffeine tablets should not be used for chronic daily administration. In carefully selected patients, with due consideration of maximum dosage recommendations, administration of the drug at bedtime may be an appropriate short-term preventive measure.
CAFERGOT® (ergotamine tartrate and caffeine tablets, USP) for oral administration are available as:
1 mg/100 mg: round tablets, sugar coated beige and imprinted CAFERGOT (ergotamine tartrate and caffeine) in black ink.
Bottles of 100...................................................NDC 0078-0349-05
Store at controlled room temperature 15° -30° C (59° -86° F).
Dispense in a tight, light-resistant container.
Manufactured By: Geneva Pharmaceuticals, Inc. Broomfield, CO 80020. Distributed By: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. Rev 03-2003. FDA Rev date: 7/26/1999
Last reviewed on RxList: 9/30/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Cafergot Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find the secrets to longer life.